Skip to Content

DV250 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint DV250 is Peach, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Genpharm Inc..

Divalproex sodium is used in the treatment of bipolar disorder; epilepsy; mania; migraine prevention; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DV250

Divalproex sodium delayed-release 250 mg DV250

Divalproex Sodium Delayed-Release

Imprint:
DV250
Strength:
250 mg
Color:
Peach
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Fatty acid derivative anticonvulsants
Pregnancy Category:
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Genpharm Inc.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide